Clinical Trial to Evaluate the Efficacy and Safety of 'URSA SOFT CAP. (UDCA-003)' in Fatigue Patients With Liver Dysfunction

Enteral Fish Oil is Superior to Ursodeoxycholic Acid (UDCA) and Placebo for the Treatment of Cholestasis in Infants

NCT02420496 ·Status: WITHDRAWN ·Phase: PHASE2

Study to Evaluate Efficacy, Safety and Tolerability of PENNEL Capsule in the Patients With Chronic Liver Disease

NCT01393665 ·Status: COMPLETED ·Phase: PHASE2

Phase II Pilot Study to Compare the Bioavailability of Buffered, Enteric-Coated Ursodiol With Unmodified Ursodiol for Chronic Cholestatic Liver Disease and Cystic Fibrosis-Associated Liver Disease

NCT00004315 ·Status: UNKNOWN ·Phase: PHASE2

The Preventative and Therapeutical Effect of Ursodeoxycholic Acid(UDCA) to Short Bowel Syndrome Patients

NCT01974336 ·Status: COMPLETED ·Phase: PHASE4

High Oral Loading Dose of Cholecalciferol in Non-Alcoholic Fatty Liver Disease

NCT05578404 ·Status: COMPLETED ·Phase: PHASE2

Ursodeoxycholic Acid Prevents Total Parenteral Nutrition Cholestasis

NCT05043194 ·Status: UNKNOWN ·Phase: NA

Treatment of Chronic Fatigue Syndrome (CFS) With Iodinated Activated Charcoal (IodoCarb®)

NCT01793415 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Ursodeoxycholic Acid in the Treatment of Intrahepatic Cholestasis of Pregnancy

NCT01576458 ·Status: COMPLETED ·Phase: PHASE3

Effects of Docosahexaenoic Acid (DHA) on Children With Nonalcoholic Fatty Liver Disease (NAFLD)

NCT00885313 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Trial of 18-22mg/kg/d Ursodeoxycholic in Refractory Primary Biliary Cholangitis

NCT03345589 ·Status: UNKNOWN ·Phase: PHASE4

DHA and Vitamin D in Children With Biopsy-proven NAFLD

NCT02098317 ·Status: COMPLETED ·Phase: PHASE3

Investigational Study of Oral Fish Oil in Treating Parenteral Nutrition Associated Liver Disease

NCT01191177 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2

Effects of Carnitine Supplementation on Liver and Muscle

NCT03439917 ·Status: COMPLETED ·Phase: NA

Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis

NCT01088607 ·Status: COMPLETED ·Phase: PHASE1

Oral Acetyl-L-Carnitine Therapy Reduces Fatigue In Hepatic Encephalopathy

NCT01223742 ·Status: COMPLETED ·Phase: NA

Hepaxa Management of Non-alcoholic Fatty Liver Disease

NCT03801577 ·Status: UNKNOWN ·Phase: NA

Elastography in Liver Cell Failure

NCT06089785 ·Status: NOT_YET_RECRUITING

Crassostrea Gigas for Liver Health

NCT02992470 ·Status: UNKNOWN ·Phase: NA

Combination Therapy With Ursodeoxycholic Acid (UDCA) and All-Trans Retinoic Acid (ATRA) for Treatment of Primary Sclerosing Cholangitis

NCT01456468 ·Status: COMPLETED ·Phase: PHASE1

Study of Obeticholic Acid (OCA) Evaluating Pharmacokinetics and Safety in Participants With Primary Biliary Cholangitis (PBC) and Hepatic Impairment

NCT03633227 ·Status: TERMINATED ·Phase: PHASE4

Chronic Fatigue Syndrome: A Presumptive Mitochondrial Disorder

NCT01471652 ·Status: WITHDRAWN ·Phase: PHASE2

Study of Aldafermin (NGM282) in Participants With Impaired Hepatic Function

NCT04823702 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Efficacy and Safety of K-808 (Pemafibrate) in Participants With Primary Biliary Cholangitis (PBC) With Inadequate Response to Ursodeoxycholic Acid (UDCA) and/or Obeticholic Acid (OCA) Treatment.

NCT06247735 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Cholic Acid for Hepatic Steatosis in Lipodystrophy

NCT00457639 ·Status: COMPLETED ·Phase: PHASE2

Nutritional Therapy of the Deficits of Oxidation Mitochondrial of the Fatty Acids

NCT00328159 ·Status: COMPLETED ·Phase: NA